Black Sea Journal of Health Science, cilt.2, sa.1, ss.9-12, 2019 (Diğer Kurumların Hakemli Dergileri)
Nowadays, biological agents such as anti-tumor necrosis factor alpha (anti-TNFα) drugs are used in the treatment of
many chronic inflammatory diseases, particularly in those cases that do not respond to conventional treatments.
However, infrequently, opportunistic infections such as bacterial, viral, fungal and parasitic infections may develop in
patients treated with anti-TNF therapy, and physicians should be cautious in terms of increased risk of infection when
using these agents. In this case report, we present a case of bilateral Cytomegalovirus (CMV) pneumonia in an
adalimumab treated patient due to ankylosing spondylitis